A carregar...
The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
Platelet transfusion is the standard treatment to control or prevent bleeding in patients with Glanzmann's thrombasthenia (GT), but platelets are often unavailable. Recombinant activated factor VII (rFVIIa) is an effective alternative to platelets in patients with GT with past/present refractor...
Na minha lista:
| Publicado no: | Thromb Haemost |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Georg Thieme Verlag KG
2021
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7895543/ https://ncbi.nlm.nih.gov/pubmed/33124022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1718373 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|